Literature DB >> 4009147

Respiratory syncytial virus polypeptides. V. The kinetics of glycoprotein synthesis.

C Gruber, S Levine.   

Abstract

The cell-associated glycoproteins of respiratory syncytial virus included GP1 (90K), VP70 (70K), VGP48 (48K) and GP26 (26K). The time course of virus protein synthesis in HeLa cells revealed that the nucleocapsid protein (VPN41) was the first to appear at 11 h post-infection followed by the appearance of the other viral proteins at 16 h post-infection. Pulse-chase experiments with [3H]leucine or [35S]methionine demonstrated that the precursor for VGP48 and GP26 was an uncleaved protein of 70K (VP70) which required at least 30 min to chase into its final products, while the precursor for GP1 was a glycoprotein of 46K, and also required at least 30 min to chase into GP1. Trypsin treatment of monensin-treated infected cells suggested that VP70 can be cleaved intracellularly into its products VGP48 and GP26.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009147     DOI: 10.1099/0022-1317-66-6-1241

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

2.  Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.

Authors:  R A Olmsted; B R Murphy; L A Lawrence; N Elango; B Moss; P L Collins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?

Authors:  Alfonsina Trento; Leyda Ábrego; Rosa Rodriguez-Fernandez; Maria Isabel González-Sánchez; Felipe González-Martínez; Adriana Delfraro; Juan M Pascale; Juan Arbiza; José A Melero
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus.

Authors:  D A Hendricks; K McIntosh; J L Patterson
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

5.  Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.

Authors:  N Elango; G A Prince; B R Murphy; S Venkatesan; R M Chanock; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus.

Authors:  G Zimmer; I Trotz; G Herrler
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.

Authors:  G W Wertz; M Krieger; L A Ball
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans.

Authors:  Steven Kwilas; Rachael M Liesman; Liqun Zhang; Edward Walsh; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

9.  The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species.

Authors:  R A Olmsted; P L Collins
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells.

Authors:  Rachel J Derscheid; Albert van Geelen; Jodi L McGill; Jack M Gallup; Tomas Cihlar; Randy E Sacco; Mark R Ackermann
Journal:  Viruses       Date:  2013-11-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.